Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors

Antibody–drug conjugates (ADCs) are a new class of targeted anti-cancer therapies that combine a monoclonal tumor-surface-receptor-targeting antibody with a highly cytotoxic molecule payload bonded through specifically designed cleavable or non-cleavable chemical linkers. One such tumor surface rece...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Blair, Greenman, Michelle, Pebley, Nicole, Mutlu, Levent, Santin, Alessandro D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650896/
https://www.ncbi.nlm.nih.gov/pubmed/37959808
http://dx.doi.org/10.3390/molecules28217389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650896/
https://www.ncbi.nlm.nih.gov/pubmed/37959808
http://dx.doi.org/10.3390/molecules28217389

Ejemplares similares